FDA / 2024

AOD-9604 Pharmacy Compounding Advisory Committee briefing

AOD-9604 Pharmacy Compounding Advisory Committee briefing — U.S. FDA (2024), cited in PeptideAgent's AOD-9604 evidence record.

Open original source

SOURCE METADATA

What this record represents.

Publisher
U.S. FDA
Evidence type
FDA
Publication year
2024
Source ID
fda-aod-briefing

WHERE THIS IS CITED

Connected evidence records.

AOD-9604Peptide fragment · Weight & Metabolism